Frenking, J., Zhou, X., Rejeski, K., Wagner, V., Costello, P., Hielscher, T., . . . Raab, M. (2025). Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma. Blood advances, 9(16), . https://doi.org/10.1182/bloodadvances.2024015732
Chicago Style (17th ed.) CitationFrenking, Jan, et al. "Bridging Intensity Is Associated with Impaired Hematopoietic Recovery After BCMA CAR-T Therapy for Multiple Myeloma." Blood Advances 9, no. 16 (2025). https://doi.org/10.1182/bloodadvances.2024015732.
MLA (9th ed.) CitationFrenking, Jan, et al. "Bridging Intensity Is Associated with Impaired Hematopoietic Recovery After BCMA CAR-T Therapy for Multiple Myeloma." Blood Advances, vol. 9, no. 16, 2025, https://doi.org/10.1182/bloodadvances.2024015732.